The global Fertility Test Market in terms of revenue was estimated to be worth $472 million in 2020 and is poised to reach $680 million by 2025, growing at a CAGR of 7.5% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
Growth in this market is primarily driven by the increasing first-time pregnancy age in women, the declining fertility rate among men and women, the growing number of women suffering from disorders such as PCOS, the emergence of advanced ovulation monitors, and the increased awareness of fertility testing in both developed and developing countries.
Download a FREE Sample Report PDF of the Global Fertility Test Market Research Report at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139945432
The Asia Pacific region is expected to grow at the highest CAGR in the fertility test industry during the forecast period.
Growth in the Asia Pacific region is primarily due to the growing number of women suffering from lifestyle disorders, increasing funding and investments towards the development of fertility and ovulation monitors, and the growing focus of both international and domestic players on the Asia Pacific fertility test market.
Swiss Precision Diagnostics (Switzerland), Church Dwight (US), Prestige Brands Holdings (US), bioZhena (US), Fairhaven Health (US), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (US), UEBE Medical (Germany), AdvaCare Pharma (US), AVA (Switzerland), Babystart (UK), Valley Electronics (Germany), Sensiia (UK), and Mira Care (US), among others, are some of the major players operating in the global fertility test market.
Based on the purchase mode, the OTC segment is expected to register significant growth in the fertility test industry during the forecast period.
Based on the mode of purchase, the fertility test market is segmented into direct/prescription, OTC, and online products. The OTC segment had the largest market share and was growing rapidly in 2020. The high growth of this segment is attributed to the inclination of patients towards self-monitoring of healthcare conditions, increasing initiatives by market players to spread awareness about fertility, and the rising preference for confidentiality and accessibility of test results.
Based on application, the female fertility testing segment is expected to account for the largest share of the fertility test industry.
The fertility test market is divided into two segments based on application: female fertility testing and male fertility testing. Female fertility testing accounted for a larger market share in 2020, owing to declining female fertility rates, the availability of a wide range of fertility testing options for females, an increase in gynaecological issues in women (such as PCOD/PCOS), and the high cost of IVF procedures.
The ovulation prediction kits segment is expected to account for the largest share in the fertility test industry during the forecast period.
Based on products, the fertility test market is segmented into ovulation prediction kits, fertility monitors, and male fertility testing products. A large share is attributed to the ovulation prediction kits segment due to the increasing use of these kits, their easy over-the-counter availability and low cost, and their higher accuracy than natural fertility testing techniques such as calendar methods and cervical mucus monitoring.
Direct Purchase of the Global Fertility Test Market Research Report at https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=139945432
The home care settings segment is expected to register the highest CAGR in the fertility test industry during the forecast period.
Based on end-users, the fertility test market has been segmented based on end-user categories—home care settings, hospitals, fertility clinics, and other end users. This segment's large share and rapid growth can be attributed to patients' preference for self-monitoring of healthcare conditions, easy access to fertility and ovulation monitors on e-commerce websites, the availability of user-friendly and easy-to-handle devices, and the growing preference for test result confidentiality.
North America dominated the global fertility test industry.
North America, comprising the US and Canada, accounted for the largest share of the fertility test market. The large share of this region can primarily be attributed to factors such as the high prevalence of infertility, increasing awareness about fertility testing among women, the rising age of first-time pregnancies in women, and the easy availability of ovulation and fertility monitors through e-commerce websites.
